Ronald DePinho
InvestorProfessor, Department of Cancer Biology and Genomic Medicine, The University of Texas MD Anderson Cancer Center at Modi Ventures
About
Ronald DePinho, M.D., is a professor in the Department of Cancer Biology and Genomic Medicine at The University of Texas MD Anderson Cancer Center, where he previously served as president. He earned his M.D. from Albert Einstein College of Medicine and has also been a professor at Harvard Medical School. His cancer research centers on telomere dysfunction and tumor suppression, and he founded the Unite to Prevent Cancer initiative.
Invests in
Biotech
Colleagues at Modi Ventures
Amir Ali
Founder, Senior Partner at Modi Ventures
Andrew Yang
Advisor (Founder, Forward Party) at Modi Ventures
Evangelia Tzika
Investment Associate at Modi Ventures
Geeta Nayyar
Advisor (Former CMO, Salesforce) at Modi Ventures
Irfan Ali
Venture Partner at Modi Ventures
J.D. Swartz
Investor at Modi Ventures
Jimmy Ku
Venture Partner at Modi Ventures
Jimmy Ku
Venture Partner at Millennia Capital
Frequently asked questions
- Who is Ronald DePinho?
- Ronald DePinho, M.D., is a professor in the Department of Cancer Biology and Genomic Medicine at The University of Texas MD Anderson Cancer Center, where he previously served as president. He earned his M.D. from Albert Einstein College of Medicine and has also been a professor at Harvard Medical School. His cancer research centers on telomere dysfunction and tumor suppression, and he founded the Unite to Prevent Cancer initiative.
- Where does Ronald DePinho work?
- Ronald DePinho is Professor, Department of Cancer Biology and Genomic Medicine, The University of Texas MD Anderson Cancer Center at Modi Ventures.
- What does Ronald DePinho invest in?
- Ronald DePinho invests in Biotech.